Clinical Trials Directory

Trials / Completed

CompletedNCT01146938

A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
18 (estimated)
Sponsor
Boryung Pharmaceutical Co., Ltd · Industry
Sex
Male
Age
20 Years – 64 Years
Healthy volunteers
Accepted

Summary

To compare and evaluate the pharmacokinetic characteristics and the safety of fimasartan in hepatic impairment patients and healthy volunteers

Conditions

Interventions

TypeNameDescription
DRUGfimasartansingle administration of fimasartan 120mg
DRUGfimasartansingle administration of fimasartan 120mg

Timeline

Start date
2010-05-01
Primary completion
2011-02-01
Completion
2011-02-01
First posted
2010-06-22
Last updated
2012-01-05

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01146938. Inclusion in this directory is not an endorsement.